- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Gilead and Novo Nordisk’s NASH trial meets primary endpoint

High magnification micrograph of steatohepatitis. Credit: Nephron.